Sex Differences in Liver Metastases at Diagnosis Across Early- and Average-Onset Gastrointestinal Adenocarcinomas
The Oncologist · 13.11.2026
DOI: 10.1093/oncolo/oyag437 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Oncologist, online erschienen am 13.11.2026. Verfasst von Nadia Kirmani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Stanford University School of Medicine, Stanford, California, United States. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
To evaluate sex differences in liver metastases at diagnosis across major gastrointestinal adenocarcinomas and assess variation by primary site and age. Design, Setting, and Participants Population-based cross-sectional study using Surveillance, Epidemiology, and End Results data (2012-2022). Patients aged 15 years or older with colorectal, esophagogastric, pancreatic, or biliary adenocarcinoma and known status of liver metastasis at diagnosis were selected. Patients with concurrent extrahepatic metastases were included. Exposure Sex and age. Main Outcomes and Measures Prevalence of synchronous liver metastases documented at diagnosis. Prevalence ratios (PRs) were estimated using modified Poisson regression with robust variance, adjusting for age, primary site, and year of diagnosis. Effect modification by primary site and age was assessed.
Results
Among 410,439 patients, the overall prevalence of liver metastases was 22.2% and higher in males than females (23.5% vs 20.6%). Female sex was associated with a lower prevalence of liver metastases (adjusted PR 0.86; 95% CI, 0.85-0.87; P < 0.001). Effect modification by primary site was observed (P for interaction < 0.001): females had lower prevalence in colorectal (PR 0.84), esophagogastric (PR 0.69), and pancreatic (PR 0.89), higher prevalence in extrahepatic biliary (PR 1.14), and no significant difference in intrahepatic biliary cancers (PR 1.04). There was also evidence of effect modification by age (P for interaction < .001), with sex differences in liver metastasis prevalence attenuating across older age groups. Conclusions and Relevance Sex differences in liver metastases at diagnosis vary by primary site and age across gastrointestinal adenocarcinomas. Female sex is associated with lower prevalence of liver metastases in most tumor types, particularly in early-onset disease, except extrahepatic biliary cancers. These findings highlight sex as a clinically relevant variable associated with metastatic presentation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Stanford University School of Medicine, Stanford, California, United States.
- Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California, United States.
- Stanford Health Care, Stanford, California, United States.
- Division of Hematology and Oncology, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States.
- Division of Oncology, Stanford University School of Medicine, Stanford, California, United States.
Zitieren
APA
Kirmani, N., Abdusamad, R., Parikh, R. V., Balakrishnan, A., Eng, C., Fisher, G., & Patel, S. (2026). Sex Differences in Liver Metastases at Diagnosis Across Early- and Average-Onset Gastrointestinal Adenocarcinomas. The Oncologist. https://doi.org/10.1093/oncolo/oyag437
Vancouver
Kirmani N, Abdusamad R, Parikh RV, Balakrishnan A, Eng C, Fisher G, et al. Sex Differences in Liver Metastases at Diagnosis Across Early- and Average-Onset Gastrointestinal Adenocarcinomas. The Oncologist. 2026. doi:10.1093/oncolo/oyag437
BibTeX
@article{Kirmani2026,
author = {Kirmani, Nadia and Abdusamad, Rania and Parikh, Rishi V and Balakrishnan, Adhvaith and Eng, Cathy and Fisher, George and Patel, Shruti},
title = {Sex Differences in Liver Metastases at Diagnosis Across Early- and Average-Onset Gastrointestinal Adenocarcinomas},
journal = {The Oncologist},
year = {2026},
doi = {10.1093/oncolo/oyag437}
}
EUVIMED